WO2006110478A3 - Mutations et polymorphismes du recepteur du facteur de croissance epidermique - Google Patents
Mutations et polymorphismes du recepteur du facteur de croissance epidermique Download PDFInfo
- Publication number
- WO2006110478A3 WO2006110478A3 PCT/US2006/012878 US2006012878W WO2006110478A3 WO 2006110478 A3 WO2006110478 A3 WO 2006110478A3 US 2006012878 W US2006012878 W US 2006012878W WO 2006110478 A3 WO2006110478 A3 WO 2006110478A3
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- mutations
- egfr
- polymorphisms
- growth factor
- factor receptor
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
- C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
- C12Q1/6886—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/106—Pharmacogenomics, i.e. genetic variability in individual responses to drugs and drug metabolism
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/156—Polymorphic or mutational markers
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/172—Haplotypes
Landscapes
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Engineering & Computer Science (AREA)
- Immunology (AREA)
- Pathology (AREA)
- Analytical Chemistry (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Genetics & Genomics (AREA)
- Hospice & Palliative Care (AREA)
- Biochemistry (AREA)
- Microbiology (AREA)
- Molecular Biology (AREA)
- Biophysics (AREA)
- Physics & Mathematics (AREA)
- Oncology (AREA)
- Biotechnology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Peptides Or Proteins (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Abstract
L'invention concerne généralement l'épreuve analytique de prélèvements de tissus in vitro et, en particulier, des aspects de polymorphismes et mutations génétiques du récepteur du facteur de croissance épidermique('epidermal growth factor receptor' ou EGFR). L'invention porte sur de nouvelles mutations du EGFR et de nouveaux polymorphismes à nucléotide unique ('single nucleotide polymorphisms' ou SNP), qui sont utilisés dans le diagnostic et le traitement de sujets qui en ont besoin. En conséquence, l'invention se rapporte, dans ses divers aspects, à des polynucléotides codant les mutations de l'EGFR de l'invention, à des vecteurs d'expression codant les polypeptides à EGFR mutant et à des organismes qui expriment les polynucléotides à EGFR mutant et polymorphes et/ou les polypeptides à EGFR mutant/polymorphe de l'invention. Les divers aspects de l'invention concernent en outre des procédés diagnostiques/théranostiques et des trousses qui font appel aux mutations et polymorphismes de l'EGFR de l'invention pour identifier les individus qui sont prédisposés à la maladie ou pour classer les individus eu égard à la réponse pharmacodynamique, aux effets secondaires ou à la dose optimale de médicament.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US67006105P | 2005-04-11 | 2005-04-11 | |
US60/670,061 | 2005-04-11 |
Publications (2)
Publication Number | Publication Date |
---|---|
WO2006110478A2 WO2006110478A2 (fr) | 2006-10-19 |
WO2006110478A3 true WO2006110478A3 (fr) | 2007-04-26 |
Family
ID=37087527
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/US2006/012878 WO2006110478A2 (fr) | 2005-04-11 | 2006-04-07 | Mutations et polymorphismes du recepteur du facteur de croissance epidermique |
Country Status (1)
Country | Link |
---|---|
WO (1) | WO2006110478A2 (fr) |
Families Citing this family (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2005070020A2 (fr) | 2004-01-23 | 2005-08-04 | The Regents Of The University Of Colorado | Expression genique relative a la sensibilite au gefitinib, produits et procedes associes |
AU2005249492B2 (en) | 2004-05-27 | 2011-09-22 | The Regents Of The University Of Colorado | Methods for prediction of clinical outcome to epidermal growth factor receptor inhibitors by cancer patients |
WO2008088885A2 (fr) * | 2007-01-18 | 2008-07-24 | Creighton University | Mutations de récepteur de facteur de croissance épidermique et procédés d'utilisation |
US9340601B2 (en) | 2007-03-01 | 2016-05-17 | The Board Of Trustees Of The Leland Stanford Junior University | Splice variants of the EGF receptor |
MX338151B (es) | 2007-03-01 | 2016-04-05 | Symphogen As | Composiciones de anticuerpo recombinante anti-receptor de factor de crecimiento epidermico. |
CN102137874B (zh) | 2008-08-29 | 2015-02-18 | 西福根有限公司 | 抗表皮生长因子受体的重组抗体组合物 |
-
2006
- 2006-04-07 WO PCT/US2006/012878 patent/WO2006110478A2/fr active Application Filing
Non-Patent Citations (7)
Title |
---|
BARBER THOMAS D ET AL: "SOMATIC MUTATIONS OF EGFR IN COLORECTAL CANCERS AND GLIOBLASTOMAS", NEW ENGLAND JOURNAL OF MEDICINE, MASSACHUSETTS MEDICAL SOCIETY, BOSTON, MA, US, vol. 351, no. 27, 30 December 2004 (2004-12-30), pages 2883, XP008069257, ISSN: 1533-4406 * |
CIARDIELLO F ET AL: "Epidermal growth factor receptor (EGFR) as a target in cancer therapy: understanding the role of receptor expression and other molecular determinants that could influence the response to anti-EGFR drugs", EUROPEAN JOURNAL OF CANCER, PERGAMON PRESS, OXFORD, GB, vol. 39, no. 10, July 2003 (2003-07-01), pages 1348 - 1354, XP004431787, ISSN: 0959-8049 * |
KOSAKA TAKAYUKI ET AL: "Mutations of the epidermal growth factor receptor gene in lung cancer: biological and clinical implications", CANCER RESEARCH, AMERICAN ASSOCIATION FOR CANCER RESEARCH, BALTIMORE, MD, US, vol. 64, no. 24, 15 December 2004 (2004-12-15), pages 8919 - 8923, XP002369912, ISSN: 0008-5472 * |
LYNCH T J ET AL: "Activating mutations in the epidermal growth factor receptor underlying responsiveness of non-small-cell lung cancer to gefitinib", NEW ENGLAND JOURNAL OF MEDICINE, MASSACHUSETTS MEDICAL SOCIETY, BOSTON, MA, US, vol. 350, no. 21, 20 May 2004 (2004-05-20), pages 2129 - 2139, XP002359960, ISSN: 1533-4406 * |
MARCHETTI A ET AL: "EGFR mutations in non-small-cell lung cancer: analysis of a large series of cases and development of a rapid and sensitive method for diagnostic screening with potential implications on pharmacologic treatment", JOURNAL OF CLINICAL ONCOLOGY, GRUNE AND STRATTON, NEW YORK, NY, US, vol. 23, no. 4, 1 February 2005 (2005-02-01), pages 857 - 865, XP002369910, ISSN: 0732-183X * |
PAEZ J G ET AL: "EGFR mutations in lung cancer: correlation with clinical response to gefitinib therapy", SCIENCE, AMERICAN ASSOCIATION FOR THE ADVANCEMENT OF SCIENCE,, US, vol. 304, no. 5676, 4 June 2004 (2004-06-04), pages 1497 - 1500, XP002359959, ISSN: 0036-8075 * |
PAO W ET AL: "EGF receptor gene mutations are common in lung cancers from never smokers and are associated with sensitivity of tumors to gefitinib and erlotinib", PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF USA, NATIONAL ACADEMY OF SCIENCE, WASHINGTON, DC, US, vol. 101, no. 36, 7 September 2004 (2004-09-07), pages 13306 - 13311, XP002334314, ISSN: 0027-8424 * |
Also Published As
Publication number | Publication date |
---|---|
WO2006110478A2 (fr) | 2006-10-19 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
WO2007016532A3 (fr) | Mutations et polymorphismes de hdac4 | |
WO2006130527A3 (fr) | Mutations et polymorphismes de recepteur du facteur de croissance 1 des fibroblastes | |
WO2006110478A3 (fr) | Mutations et polymorphismes du recepteur du facteur de croissance epidermique | |
EP2293074A3 (fr) | Procédé pour le diagnostic de maladies neuro-dégénératives | |
MX2009003562A (es) | Ensayo elisa para la deteccion de vegf. | |
WO2004044557A3 (fr) | Mesure non invasive d'analytes | |
WO2010025341A3 (fr) | Détermination de tranches d’âge d’échantillons cutanés | |
WO2002086448A3 (fr) | Detection de l'instabilite des microsatellites et son utilisation dans le diagnostic des tumeurs | |
EP2011885A3 (fr) | Procédé de diagnostic de cancer de la vessie | |
EP2503338A3 (fr) | CD73 comme biomarqueur pour surveiller le développement de maladies et évaluer l'efficacité des thérapies | |
WO2010053587A3 (fr) | Procédés de surveillance de maladies par analyse de séquence | |
WO2006058306A3 (fr) | Imagerie medicale en hyperespace spectral destinee a l'evaluation de tissus et de tumeurs | |
EP1907845A4 (fr) | Diagnostic de maladies et d'états pathologiques par l'analyse d'échantillons biologiques traités par voie histopathologique à l'aide de préparations tissulaires liquides | |
EP2287340A3 (fr) | Procédé de diagnostic et traitement d'une maladie mentale | |
WO2007016367A3 (fr) | Procedes, kits, systemes et bases de donnees relatifs a des maladies neoplasiques | |
WO2006055524A3 (fr) | Biomarqueurs pour le diagnostic de la schizophrenie et du trouble bipolaire | |
WO2002022879A3 (fr) | Detection de l'instabilite des microsatellites et utilisation de celle-ci dans le diagnostic de tumeurs | |
GB0516145D0 (en) | In vitro diagnostic kit for identification of human papillomavirus in clinical samples | |
WO2007022041A3 (fr) | Mutations et polymorphismes de l'hdac3 | |
WO2007030455A3 (fr) | Mutations et polymorphismes de hdac10 | |
WO2006003414A3 (fr) | Biomarqueurs de la maladie d'alzheimer | |
WO2007038073A3 (fr) | Mutations et polymorphismes de l’hdac11 | |
BRPI0412110A (pt) | genes regulados no cáncer ovariano como alvos prognósticos e terapêuticos | |
WO2007030454A3 (fr) | Mutations et polymorphismes de hdac9 | |
WO2007058992A3 (fr) | Mutations et polymorphismes de hdac6 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
NENP | Non-entry into the national phase |
Ref country code: DE |
|
NENP | Non-entry into the national phase |
Ref country code: RU |
|
122 | Ep: pct application non-entry in european phase |
Ref document number: 06740651 Country of ref document: EP Kind code of ref document: A2 |